Organ on a Chip is of great interest at the moment. A recent USA Market Research Report has predicted it will be the fastest growing segment of the in vitro cell culture market reaching $6.1 Billion by 2025. The technology will be disruptive and hence will create both opportunities and threats for all those involved in biomedical research. This newly developed course from FSRM will enable you to understand the technology and the underlying commercial factors behind the rapid changes that are taking place.
Course: Using Organ-on-Chip technology to reduce animal testing
Date: October 30-31, 2017
Location: Barcelona, Institute for Bioengineering of Catalonia IBEC
Deadline of registration: October 16, 2017
Detailed information here.
This course will provide you with
a state of the art review of current methods for in-vitro testing of safety and efficacy of chemicals (including drugs) as well as studying disease and more general medical research.
a detailed description of the latest advances in the technologies used for cell culture and the monitoring of cell function.
A description of the barriers and drivers to change, particularly the reduction and replacement of animal testing (ethical, scientific, economic).
A description of the technical challenges in creating and maintaining cell culture in a way that mimics the human environment (ie physiologically relevant models).
An analysis of the specific challenges of scaling in-vitro models to the micro-scale needed to create the organ or human-on-a-chip.
For further questions please contact Annette LOCHER at FSRM: firstname.lastname@example.org; +41 32 720 09 03